161 related articles for article (PubMed ID: 9748046)
1. Minimal number of plasma exchanges needed to reduce immunoglobulin in Guillain-Barré syndrome.
Yuki N; Tagawa Y; Hirata K
Neurology; 1998 Sep; 51(3):875-7. PubMed ID: 9748046
[TBL] [Abstract][Full Text] [Related]
2. [The number of plasma exchanges in Guillain-Barré syndrome: evaluation by the removal rate of immunoglobulin G].
Tagawa Y; Yuki N; Hirata K
Rinsho Shinkeigaku; 1998; 38(10-11):951-4. PubMed ID: 10203982
[TBL] [Abstract][Full Text] [Related]
3. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
4. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
Tagawa Y; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
[TBL] [Abstract][Full Text] [Related]
5. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
Ann Neurol; 1997 Mar; 41(3):298-306. PubMed ID: 9066350
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to GD3, GT3, and O-acetylated species in Guillain-Barré and Fisher's syndromes: their association with cranial nerve dysfunction.
Koga M; Yuki N; Ariga T; Hirata K
J Neurol Sci; 1999 Mar; 164(1):50-5. PubMed ID: 10385047
[TBL] [Abstract][Full Text] [Related]
7. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.
Shahrizaila N; Yuki N
Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076
[TBL] [Abstract][Full Text] [Related]
8. [Immunoglobulins or plasma exchange? Guillain-Barré syndrome: indications for plasma exchange and immunoglobulins].
Raphaël JC; Chevret S; Jars-Guincestre MC; Chastang C; Gajdos P
Ann Med Interne (Paris); 1993; 144(8):526-31. PubMed ID: 8179242
[TBL] [Abstract][Full Text] [Related]
9. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
Ann Neurol; 1992 Jul; 32(1):94-7. PubMed ID: 1642477
[TBL] [Abstract][Full Text] [Related]
10. [No association between IgG anti-GTla antibody and bulbar palsy in Guillain-Barré and Fisher's syndromes].
Koga M; Yuki N; Hirata K
Rinsho Shinkeigaku; 1997 Nov; 37(11):1024-6. PubMed ID: 9503976
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
[TBL] [Abstract][Full Text] [Related]
12. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
[TBL] [Abstract][Full Text] [Related]
13. New concepts of Guillain-Barré syndrome.
Asbury AK
J Child Neurol; 2000 Mar; 15(3):183-91. PubMed ID: 10757475
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
[TBL] [Abstract][Full Text] [Related]
15. Plasma exchange versus intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA
Ther Apher; 1997 May; 1(2):129-30. PubMed ID: 10225757
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review.
Kaida K; Kusunoki S
J Neuroimmunol; 2010 Jun; 223(1-2):5-12. PubMed ID: 20172612
[TBL] [Abstract][Full Text] [Related]
17. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.
Kleyweg RP; van der Meché FG
J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):957-60. PubMed ID: 1800666
[TBL] [Abstract][Full Text] [Related]
18. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.
Yuki N; Susuki K; Hirata K
Neurology; 2000 May; 54(9):1851-3. PubMed ID: 10802797
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of anti-glycolipid antibody-associated neuropathy].
Yuki N
Rinsho Shinkeigaku; 1999 Dec; 39(12):1232-4. PubMed ID: 10791085
[TBL] [Abstract][Full Text] [Related]
20. [Acute relapsing Guillain-Barré syndrome after 5 and 7 years asymptomatic intervals].
Kawada Y; Fujita N; Yuki N; Ohashi T; Ohnishi Y
Rinsho Shinkeigaku; 1992 Feb; 32(2):187-90. PubMed ID: 1611778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
